Zacks Investment Research on MSN
Eli Lilly's next-generation obesity drug secures first phase III win
Shares of Eli Lilly LLY rose nearly 2% on Thursday after the company announced that a late-stage study evaluating its ...
The weight-loss drug market is booming, with biotech firms racing to secure their place in a lucrative sector currently ...
Dec 12 () - The weight-loss drug market is booming, with biotech firms racing to secure their place in a lucrative sector ...
Propelled by a flurry of dealmaking late in the year, 2025 M&A ended on a strong note, with high activity expected to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback